Sitagliptin (trade names: Januvia and Xelevia) is approved for certain adults with type 2 diabetes mellitus whose blood-glucose levels are inadequately controlled by diet and exercise alone. The fixed ...
Please provide your email address to receive an email when new articles are posted on . “Clinical practice guidelines recommend adding second-line agents, such as DPP-IV inhibitors, if glycemic ...
Janumet™ (MK-0431A) combines two OADs with complementary mechanisms of action to improve glycemic control, sitagliptin and metformin. The tablet was designed in order to be bioequivalent to ...
FDA is revising the prescribing information for Januvia (sitagliptin) and Janumet (sitagliptin/metformin) to include information on reported cases of acute ...
Do not use if you have ever had an allergic reaction to SITAGLIPTIN/METFORMIN MYLAN or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions ...
Sitagliptin, metformin (as HCl) ext-rel; 50mg/500mg, 50mg/1000mg, 100mg/1000mg; tabs. Individualize. Swallow whole. Take once daily with a meal, preferably in the evening. Not currently treated with ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- New data were presented at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions from a study comparing ...
Compared with adults on sulfonylurea plus metformin, adults prescribed sitagliptin plus metformin had significantly better adherence and persistence, study data show. “In this observational study ...
Study Finds That ONGLYZA™ (saxagliptin) When Added To Metformin Was Non-Inferior To JANUVIA (SITAGLIPTIN) When Added To Metformin In Reducing Hemoglobin (HbA1c) In Adults With Type 2 Diabetes Mellitus ...
Merck Receives Positive CHMP Opinion for JANUVIA® (sitagliptin) and JANUMET® (sitagliptin/metformin) as Add-On to Insulin in the European Union WHITEHOUSE STATION ...
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. SITAGLIPTIN/METFORMIN XR MYLAN contains the active ingredients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results